MKC:NYSEMcCormick & Company, Incorporated Analysis
Data as of 2026-03-13 - not real-time
$58.67
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
McCormick & Co. (MKC) is trading at $58.66, well below its 50‑day SMA of $66.19 and the 200‑day SMA of $68.41, indicating a short‑term downtrend. However, the RSI of 30 suggests the stock is oversold and approaching its near‑term support at $57.29, while the 30‑day volatility of 37% and a low beta of 0.33 point to heightened price swings but limited market correlation. The company delivers a solid dividend yield of 3.35% with a payout ratio of 61%, and fundamentals such as a 14% ROE, 2.9% revenue growth, and a forward PE of 17.45 reinforce its defensive character.
Recent material news includes a scheduled Q1 earnings release on March 31, UBS cutting its price target, and insider sales by a director, which temper optimism. Yet the median analyst price target of $75 implies roughly 28% upside, and the stock’s crossing above its 200‑day moving average hints at a potential longer‑term trend reversal. Overall, the blend of attractive yield, decent profitability, and undervalued technical positioning creates a nuanced investment case.
Recent material news includes a scheduled Q1 earnings release on March 31, UBS cutting its price target, and insider sales by a director, which temper optimism. Yet the median analyst price target of $75 implies roughly 28% upside, and the stock’s crossing above its 200‑day moving average hints at a potential longer‑term trend reversal. Overall, the blend of attractive yield, decent profitability, and undervalued technical positioning creates a nuanced investment case.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI near oversold levels (30) indicating possible bounce
- Price hovering just above key support at $57.29
- Recent insider selling and UBS target reduction adding downside pressure
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Median analyst target of $75 suggests ~28% upside
- Strong dividend yield (3.35%) and sustainable payout
- Fundamental stability: ROE 14%, forward PE 17.45, modest revenue growth
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Defensive consumer sector with low beta (0.33) offering resilience
- Consistent cash flow generation supporting dividend continuity
- Elevated debt-to-equity (73%) warrants caution over extended horizons
Key Metrics & Analysis
Financial Health
Revenue Growth2.90%
Profit Margin11.54%
P/E Ratio20.0
ROE14.24%
ROA5.23%
Debt/Equity73.21
P/B Ratio2.7
Op. Cash Flow$962.2M
Free Cash Flow$564.5M
Technical Analysis
TrendNeutral
RSI30.3
Support$57.29
Resistance$72.41
MA 20$66.67
MA 50$66.19
MA 200$68.41
MACDBearish
VolumeDecreasing
Fear & Greed Index73.09
Valuation
Fair Value$17.31
Target Price$73.85
Upside/Downside25.88%
GradeFair
TypeBlend
Dividend Yield3.35%
Risk Assessment
Beta0.33
Volatility37.43%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.